• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子信号转导抑制因子2:JAK2V617F介导的信号转导抑制剂。

SOCS2: inhibitor of JAK2V617F-mediated signal transduction.

作者信息

Quentmeier H, Geffers R, Jost E, Macleod R A F, Nagel S, Röhrs S, Romani J, Scherr M, Zaborski M, Drexler H G

机构信息

DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany.

出版信息

Leukemia. 2008 Dec;22(12):2169-75. doi: 10.1038/leu.2008.226. Epub 2008 Sep 4.

DOI:10.1038/leu.2008.226
PMID:18769447
Abstract

Janus kinase 2 (JAK2)V617F-activating mutations (JAK2mu) occur in myeloproliferative disorders (MPDs) and myelodysplastic syndromes (MDSs). Cell lines MB-02, MUTZ-8, SET-2 and UKE-1 carry JAK2V617F and derive from patients with MPD/MDS histories. Challenging the consensus that expression of JAK2V617F is the sole precondition for cytokine independence in class I cytokine receptor-positive cells, two of four of the JAK2mu cell lines were growth factor-dependent. These cell lines resembled JAK2wt cells regarding JAK2/STAT5 activation: cytokine deprivation effected dephosphorylation, whereas erythropoetin or granulocyte colony-stimulating factor induced phosphorylation of JAK2 and STAT5. Cytokine independence correlated with low expression and cytokine dependence with high expression of the JAK/STAT pathway inhibitor suppressor of cytokine signaling 2 (SOCS2) suggesting a two-step mechanism for cytokine independence of MPD cells: (i) activation of the oncogene JAK2V617F and (ii) inactivation of the tumor suppressor gene SOCS2. Confirming that SOCS2 operates as a negative JAK2V617F regulator, SOCS2 knockdown induced constitutive STAT5 phosphorylation in JAK2mu cells. CpG island hypermethylation is reported to promote SOCS gene silencing in malignant diseases. Accordingly, in one of two cytokine-independent cell lines and in two of seven MPD patients, we found SOCS2 hypermethylation associated with reduced promoter access to transcription factors. Our results provide solid evidence that SOCS2 epigenetic downregulation might be an important second step in the genesis of cytokine-independent MPD clones.

摘要

Janus激酶2(JAK2)V617F激活突变(JAK2mu)发生于骨髓增殖性疾病(MPD)和骨髓增生异常综合征(MDS)。细胞系MB - 02、MUTZ - 8、SET - 2和UKE - 1携带JAK2V617F,源自具有MPD/MDS病史的患者。对于I类细胞因子受体阳性细胞中JAK2V617F的表达是细胞因子非依赖性的唯一前提这一共识提出挑战的是,四个JAK2mu细胞系中有两个依赖生长因子。这些细胞系在JAK2/STAT5激活方面类似于JAK2野生型细胞:细胞因子剥夺导致去磷酸化,而促红细胞生成素或粒细胞集落刺激因子诱导JAK2和STAT5磷酸化。细胞因子非依赖性与JAK/STAT途径抑制剂细胞因子信号转导抑制因子2(SOCS2)的低表达相关,细胞因子依赖性与高表达相关,提示MPD细胞的细胞因子非依赖性存在两步机制:(i)癌基因JAK2V617F的激活和(ii)肿瘤抑制基因SOCS2的失活。证实SOCS2作为JAK2V617F的负调节因子起作用的是,SOCS2敲低诱导JAK2mu细胞中组成型STAT5磷酸化。据报道,CpG岛高甲基化促进恶性疾病中SOCS基因沉默。因此,在两个细胞因子非依赖性细胞系之一以及七名MPD患者中的两名患者中,我们发现SOCS2高甲基化与启动子对转录因子的可及性降低相关。我们的结果提供了确凿证据,表明SOCS2的表观遗传下调可能是细胞因子非依赖性MPD克隆发生过程中的重要第二步。

相似文献

1
SOCS2: inhibitor of JAK2V617F-mediated signal transduction.细胞因子信号转导抑制因子2:JAK2V617F介导的信号转导抑制剂。
Leukemia. 2008 Dec;22(12):2169-75. doi: 10.1038/leu.2008.226. Epub 2008 Sep 4.
2
[Study of hypermethylation of SOCS gene in typical myeloproliferative disease].[典型骨髓增殖性疾病中细胞因子信号转导抑制因子基因高甲基化的研究]
Zhonghua Xue Ye Xue Za Zhi. 2011 Nov;32(11):772-6.
3
Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders.在BCR/ABL阴性骨髓增殖性疾病患者中,表观遗传改变是JAK2酪氨酸激酶突变的补充。
Leukemia. 2007 Mar;21(3):505-10. doi: 10.1038/sj.leu.2404513. Epub 2007 Jan 18.
4
JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.源自骨髓增殖性疾病的细胞系中的JAK2 V617F酪氨酸激酶突变。
Leukemia. 2006 Mar;20(3):471-6. doi: 10.1038/sj.leu.2404081.
5
Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.组蛋白去乙酰化酶抑制剂丁酸钠通过抑制 HDAC8 介导的 SOCS1 和 SOCS3 的上调来抑制骨髓增殖性肿瘤中的 JAK2/STAT 信号通路。
Exp Hematol. 2013 Mar;41(3):261-70.e4. doi: 10.1016/j.exphem.2012.10.012. Epub 2012 Oct 27.
6
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.MPLW515L是骨髓纤维化伴髓外化生中的一种新型体细胞激活突变。
PLoS Med. 2006 Jul;3(7):e270. doi: 10.1371/journal.pmed.0030270.
7
Epigenetic deregulated miR-375 contributes to the constitutive activation of JAK2/STAT signaling in myeloproliferative neoplasm.表观遗传失调的miR-375促成骨髓增殖性肿瘤中JAK2/STAT信号通路的组成性激活。
Leuk Res. 2015 Apr;39(4):471-8. doi: 10.1016/j.leukres.2015.01.009. Epub 2015 Jan 28.
8
Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.费城染色体阴性慢性骨髓增殖性疾病中细胞因子信号转导抑制因子的表观遗传失活
Br J Haematol. 2008 May;141(4):504-11. doi: 10.1111/j.1365-2141.2008.07072.x. Epub 2008 Mar 3.
9
JAK2V617F-negative ET patients do not display constitutively active JAK/STAT signaling.JAK2V617F阴性的原发性血小板增多症患者未表现出组成性激活的JAK/STAT信号传导。
Exp Hematol. 2007 Nov;35(11):1695-703. doi: 10.1016/j.exphem.2007.07.004. Epub 2007 Aug 30.
10
JAK/STAT signal transduction: regulators and implication in hematological malignancies.JAK/STAT信号转导:调控因子及其在血液系统恶性肿瘤中的意义
Biochem Pharmacol. 2006 Mar 14;71(6):713-21. doi: 10.1016/j.bcp.2005.12.017. Epub 2006 Jan 19.

引用本文的文献

1
Loss of Socs2 improves molecular responses to IFNα in a mouse model of myeloproliferative neoplasms driven by JAK2-V617F.在由JAK2-V617F驱动的骨髓增殖性肿瘤小鼠模型中,Socs2缺失改善了对IFNα的分子反应。
Leukemia. 2025 Apr;39(4):876-887. doi: 10.1038/s41375-025-02550-5. Epub 2025 Mar 11.
2
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer.JAK-STAT 信号通路的认知演变:自身免疫性疾病和癌症。
Signal Transduct Target Ther. 2023 May 19;8(1):204. doi: 10.1038/s41392-023-01468-7.
3
Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research.
选择合适的细胞系进行急性髓系白血病(AML)研究。
Int J Mol Sci. 2023 Mar 11;24(6):5377. doi: 10.3390/ijms24065377.
4
Identification of the Prognostic Value Among Suppressor Of Cytokine Signaling Family Members in Kidney Renal Clear Cell Carcinoma.细胞因子信号转导抑制因子家族成员在肾透明细胞癌中的预后价值鉴定
Front Mol Biosci. 2021 Dec 2;8:585000. doi: 10.3389/fmolb.2021.585000. eCollection 2021.
5
A comprehensive genome-wide analysis of long non-coding RNA and mRNA expression profiles of JAK2V617F-positive classical myeloproliferative neoplasms.JAK2V617F 阳性经典骨髓增殖性肿瘤的长非编码 RNA 和 mRNA 表达谱的全基因组综合分析。
Bioengineered. 2021 Dec;12(2):10564-10586. doi: 10.1080/21655979.2021.2000226.
6
SOCS Proteins in Immunity, Inflammatory Diseases, and Immune-Related Cancer.免疫、炎症性疾病和免疫相关癌症中的细胞因子信号传导抑制蛋白(SOCS)
Front Med (Lausanne). 2021 Sep 16;8:727987. doi: 10.3389/fmed.2021.727987. eCollection 2021.
7
SOCS2 is a potential prognostic marker that suppresses the viability of hepatocellular carcinoma cells.信号转导和转录激活因子2(SOCS2)是一种潜在的预后标志物,可抑制肝癌细胞的活力。
Oncol Lett. 2021 May;21(5):399. doi: 10.3892/ol.2021.12660. Epub 2021 Mar 18.
8
STAT5 is Expressed in CD34/CD38 Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.信号转导和转录激活因子5(STAT5)在CD34/CD38干细胞中表达,并作为阴性骨髓增殖性肿瘤的潜在分子靶点。
Cancers (Basel). 2020 Apr 21;12(4):1021. doi: 10.3390/cancers12041021.
9
Development and validation of a 10-gene prognostic signature for acute myeloid leukaemia.开发和验证用于急性髓细胞白血病的 10 个基因预后签名。
J Cell Mol Med. 2020 Apr;24(8):4510-4523. doi: 10.1111/jcmm.15109. Epub 2020 Mar 9.
10
Complement factor H‑related 3 overexpression affects hepatocellular carcinoma proliferation and apoptosis.补体因子 H 相关蛋白 3 过表达影响肝细胞癌的增殖和凋亡。
Mol Med Rep. 2019 Sep;20(3):2694-2702. doi: 10.3892/mmr.2019.10514. Epub 2019 Jul 23.